XML 23 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share Capital
3 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
7.
Share Capital
 
 
Reverse Share Split
 
On May 4, 2018, the Company effected a share consolidation (reverse split) of the Company's common shares at a ratio of 1-for-7.
As a result of the reverse split, every seven shares of the issued and outstanding common shares, without par value, consolidated into one newly-issued outstanding common share, without par value, after fractional rounding. The number of warrants and options were proportionately adjusted by the split ratio and the exercise prices correspondingly increased by the same split ratio.
All shares and exercise prices are presented on a post-split basis in these condensed interim consolidated financial statements.
 
Black-Scholes option valuation model
 
The Company uses the Black-Scholes option valuation model to determine the fair value of share-based compensation for placement agent warrants and share options granted. Option valuation models require the input of highly subjective assumptions including the expected price volatility. The Company has used historical volatility to estimate the volatility of the share price. Changes in the subjective input assumptions can materially affect the fair value estimates, and therefore the existing models do not necessarily provide a reliable single measure of the fair value of the Company’s warrants and share options.
 
Warrants
 
A summary of the Company’s warrants activity is as follows:
 
 
 
Number of

Warrants
 
 
Weighted

Average

Exercise Price
 
 
 
 
 
 
 
 
Balance - September 30, 2017
 
 
180,805
 
 
$
31.50
 
 
 
 
 
 
 
 
 
 
Granted
 
 
5,665,528
 
 
 
2.68
 
Granted pre-funded warrants
 
 
687,076
 
 
 
.01
 
Exercised
 
 
(1,752,373
)
 
 
2.65
 
Exercised pre-funded warrants
 
 
(687,076
)
 
 
.01
 
 
 
 
 
 
 
 
 
 
Balance - September 30, 2018
 
 
4,093,960
 
 
$
3.96
 
 
 
 
 
 
 
 
 
 
Expired
 
 
(2,044,152
)
 
 
2.65
 
 
 
 
 
 
 
 
 
 
Balance - December 31, 2018
 
 
2,049,808
 
 
$
5.27
 
 
The weighted average contractual life remaining on the outstanding warrants at December 31, 2018 is 51 months.
 
The following table summarizes information about the warrants outstanding at December 31, 2018:
 
Exercise Price
 
 
Number of

Warrants
 
 
Expiry Date
 
 
 
 
 
 
 
$
31.50
 
 
 
180,805
 
 
January 2022
 
2.65
 
 
 
1,645,175
 
 
May 2023
 
3.31
 
 
 
223,828
 
 
May 2023
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,049,808
 
 
 
 
Share Options
 
The Company adopted an incentive compensation plan in 2017 (the Incentive Plan), which amended and restated the 2013 fixed share option plan and is administered by the Board of Directors. Options, restricted shares and restricted share units are eligible for grants under the Incentive Plan. The number of shares available for issuance under the Incentive Plan is 228,143, including shares available for the exercise of outstanding options under the 2013 fixed share option plan. No restricted shares or restricted share units have been granted as of December 31, 2018.
 
The exercise price of an option is set at the closing price of the Company’s common shares on the date of grant. Share options granted to directors, officers, employees and certain individual consultants for past service are subject to the following vesting schedule: (a) one-third shall vest immediately, (b) one-third shall vest at 12 months from the date of grant and (c) one-third shall vest at 18 months from the date of grant.
 
Share options granted to directors, officers, employees and certain individual consultants for future service are subject to the following vesting schedule: (x) one-third shall vest at 12 months from the date of grant, (y) one-third shall vest at 24 months from the date of grant and (z) one-third shall vest at 36 months from the date of grant.
 
Share options granted to certain individual investor relations consultants are subject to the following vesting schedule: (aa) 25% shall vest at 3 months from the date of grant, (bb) 25% shall vest at 6 months from the date of grant, (cc) 25% shall vest at 12 months from the date of grant and (dd) 25% shall vest at 15 months from the date of grant.
 
Options have been granted under the Incentive Plan allowing the holders to purchase common shares of the Company as follows:
 
 
 
Number of

Options
 
 
Weighted

Average

Exercise Price
 
 
 
 
 
 
 
 
 
 
 
 
Balance - September 30, 2017
 
 
58,711
 
 
$
40.18
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
29,426
 
 
 
5.88
 
 
 
Expired
 
 
(2,266
)
 
 
84.87
 
 
 
Expired
 
 
(15,373
)
 
 
42.07
 
 
CDN $
 
 
 
 
 
 
 
 
 
 
 
Balance - September 30, 2018
 
 
70,498
 
 
$
25.42
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expired
 
 
(2,203
)
 
 
11.44
 
 
 
Expired
 
 
(1,786
)
 
 
117.19
 
 
CDN $
 
 
 
 
 
 
 
 
 
 
 
Balance – December 31, 2018
 
 
66,509
 
 
$
23.60
 
 
 
 
The weighted average contractual life remaining on the outstanding options is 47 months.
 
The following table summarizes information about the options under the Incentive Plan outstanding and exercisable at December 31, 2018:
 
Number of

Options
 
 
Exercisable at

December 31, 2018
 
 
Range of exercise prices
 
Expiry Dates
 
13,479
 
 
 
13,479
 
 
 CDN$15.00 - 35.00
 
Apr 2019-Dec 2019
 
37,985
 
 
 
17,534
 
 
 $5.00 - 20.00
 
Sep 2023-Mar 2025
 
7,214
 
 
 
7,214
 
 
 CDN$40.00 - 70.00
 
May 2020-Jun 2022
 
1,972
 
 
 
1,972
 
 
 $50.00 - 60.00
 
Dec 2022
 
1,644
 
 
 
1,644
 
 
 CDN$105.00 - 140.00
 
Nov 2018-Nov 2021
 
4,215
 
 
 
4,215
 
 
 $120.00 - 130.00
 
Nov 2020
 
66,509
 
 
 
46,058
 
 
 
 
 
 
As of December 31, 2018, the Company had approximately $44,000 of unrecognized share-based compensation expense, which is expected to be recognized over a period of 25 months.
 
There were no options granted or exercised during the three months ended December 31, 2018 and 2017.